Whenever we have featured founders who have scaled their businesses meaningfully, it is typically because they have been good at acquiring customers and increasing their lifetime value.

But Mayur Abhaya, our guest in this episode, has scaled LifeCell to an annual revenue of about 800 crores on the back of its strong supply chain & delivery capabilities.

Mayur’s father was a serial entrepreneur in the pharma and healthcare space and built Shasun Pharma into a 500-million-dollar global pharma manufacturing player. He also set up Lifecell as he saw the gap in the market for stem cell banking. Mayur joined the business when the topline was just 20 crores and over the last 16 years has expanded the business both geographically and in terms of product lines.

Today just one fourth of their turnover comes from the original business line of stem cell banking, and some of their business lines are around delivering cutting edge healthcare products to the Indian consumer at amazingly affordable prices.

If you care about health-tech then there is no better episode than this for a deeper understanding of the space. Stay tuned and subscribe to the Founder Thesis podcast with your host Akshay Datt.

The science of healthcare scale up | Mayur Abhaya @ LifeCell